Table 2

Anthropometric (prepregnancy and at screening) and laboratory characteristics at screening according to glucose tolerance status during pregnancy

Variables

Groups

p-value

IA

IB

IIA

IIB

Height (meter)

1.65 ± 0.07

1.64 ± 0.05

1.61 ± 0.05

1.60 ± 0.05

0.001⁽¹⁾

Legs length (cm)

76.0 ± 4.8

75.3 ± 4.0

73.3 ± 4.1

73.1 ± 4.1

0.014⁽²⁾

BMI

Prepregnancy

23.1 ± 4.5

25.8 ± 6.1

27.8 ± 7.6

28.5 ± 6.9

0.001⁽³⁾

At screening

25.6 ± 4.3

29.3 ± 6.1

31.0 ± 6.9

31.4 ± 6.0

<0.001⁽⁴⁾

Waist

Prepregnancy

69.6 ± 5.1

81.5 ± 11.3

90.3 ± 18.6

101.8 ± 15.1

<0.001⁽⁵⁾

At screening

95.9 ± 10.1

104.5 ± 11.3

107.6 ± 14.4

108.2 ± 9.8

<0.001⁽⁶⁾

Waist-to-hip ratio

Prepregnancy

0.76 ± 0.06

0.76 ± 0.05

0.86 ± 0.11

0.87 ± 0.11

0.040

At screening

0.93 ± 0.07

0.95 ± 0.07

0.97 ± 0.04

0.99 ± 0.07

0.002 ⁽⁷⁾

Systolic blood pressure (mmHg)

Prepregnancy

108.4 ± 7.8

115.5 ± 23.3

114.7 ± 14.1

125.4 ± 25.8

0.003⁽⁸⁾

At screening

107.7 ± 9.9

111.0 ± 12.5

114.7 ± 11.7

120.6 ± 17.6

0.002⁽⁹⁾

Diastolic blood pressure (mmHg)

Prepregnancy

71.0 ± 8.2

75.0 ± 14.1

75.8 ± 9.3

81.2 ± 12.9

0.003⁽¹⁰⁾

At screening

71.5 ± 9.2

74.5 ± 10.8

76.4 ± 11.1

79.3 ± 12.2

0.02⁽¹¹⁾

At screening

Fasting glucose(mg/dl)

73.7 ± 8.7

74.8 ± 9.6

87.2 ± 11.7

114.4 ± 23.6

<0.001⁽¹²⁾

HbA_1c (%)

4.57 ± 0.45

4.95 ± 0.59

5.15 ± 0.71

5.98 ± 1.00

<0.001⁽¹³⁾

Total cholesterol(mg/dl)

229.2 ± 43.5

236.7 ± 44.5

221.4 ± 42.3

195.5 ± 43.0

0.001⁽¹⁴⁾

LDL cholesterol(mg/dl)

124.2 ± 41.5

130.2 ± 37.8

111.6 ± 34.6

94.2 ± 33.0

0.001⁽¹⁵⁾

HDL cholesterol(mg/dl)

69.0 ± 16.9

66.1 ± 16.4

73.1 ± 21.3

57.8 ± 16.2

0.014⁽¹⁶⁾

VLDL cholesterol(mg/dl)

34.8 ± 12.0

39.4 ± 13.3

36.5 ± 13.9

43.4 ± 11.7

0.037⁽¹⁷⁾

Triglycerides (mg/dl)

174.3 ± 60.4

215.7 ± 131.7

182.8 ± 69.5

217.3 ± 58.5

0.016⁽¹⁸⁾

(1) p < 0.05 IIB vs IB, IA; IIA vs IA;

(2) p < 0.05 IA vs IIB, IIA, IB;

(3) p < 0.05 IA vs IIA, IIB;

(4) p < 0.05 IA vs IB, IIA, IIB;

(5) p < 0.05 IA vs IB, IIA, IIB;

(6) p < 0.05 IA vs IB, IIA, IIB;

(7) p < 0.05 IA vs IIA, IIB; IB vs IIB;

(8) p < 0.01 IA vs IIB;

(9) p < 0.01 IA vs IIB;

(10) p < 0.01 IA vs IIB;

(11) p < 0.05 IA vs IIB;

(12) p < 0.001 IA vs IIB, IB vs IIB; p < 0.01 IA vs IIA; p < 0.05 IB vs IIA, IIA vs IIB;

(13) p < 0.001 IA vs IIB; IB vs IIB;

(14) p < 0.05 IIB vs IIA, IA, IB;

(15) p < 0.05 IIB vs IA, IB;

(16) p < 0.05 IIB vs IA, IIA;

(17) p < 0.05 IA vs IIB;

(18) p < 0.05 IA vs IIB;

Negrato et al. Diabetology & Metabolic Syndrome 2009 1:3   doi:10.1186/1758-5996-1-3